Home > Publications > Influenza Bibliography
 

June 1999 :: Vol 29 No 6

Clinical and prevention

  1. ANDERSON, H., Petrie, K., Berrisford, C., Charlett, A., Thatcher, N., and Zambon, M.
    Seroconversion after influenza vaccination in patients with lung cancer.
    British Journal of Cancer, 1999, 80(1-2), 219-220.
  2. ANONYMOUS
    Acute respiratory infections, and influenza vaccine for 1999/2000.
    Communicable Disease Report. CDR Weekly, 1999, 9(10), 87, 90.
  3. BOERSMA, B., Rhames, T., and Keegan, J. M.
    Additional cost savings of an effective employee influenza program on prevention of nosocomial influenza [letter].
    American Journal of Infection Control, 1999, 27(2), 177-8.
  4. CRAWFORD, J., Wilkinson, B., Vosnesensky, A., Smith, G., Garcia, M., Stone, H., and Perdue, M. L.
    Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes.
    Vaccine, 1999, 17(18), 2265-2274.
  5. GROSS, P. A., Sperber, S. J., Donabedian, A., Dran, S., Morchel, G., Cataruozolo, P., and Munk, G.
    Paradoxical response to a novel influenza virus vaccine strain: the effect of prior immunization.
    Vaccine, 1999, 17(18), 2284-2289.
  6. HOWES, P. D., Cleasby, A., Evans, D. N., Feilden, H., Smith, P. W., Sollis, S. L., Taylor, N., and Wonacott, A. J.
    4-Acetylamino-3-(Imidazol-1-yl)-benzoic acids as novel inhibitors of influenza sialidase.
    European Journal of Medicinal Chemistry, 1999, 34(3), 225-234.
  7. JOHNSTON, S. D., Kempston, A., and Robinson, T. J.
    Pneumonitis secondary to the influenza vaccine.
    Postgraduate Medical Journal, 1998, 74(875), 541-2.
  8. KEECH, M., Scott, A. J., and Ryan, P. J.
    The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population.
    Occupational Medicine, 1998, 48(2), 85-90.
  9. LEIGHTON, L., Williams, M., Aubery, D., and Parker, S. H.
    Sickness absence following a campaign of vaccination against influenza in the workplace.
    Occupational Medicine, 1996, 46(2), 146-50.
  10. LI, S. Q., Liu, C. G., Klimov, A., Subbarao, K., Perdue, M. L., Mo, D., Ji, Y. Y., Woods, L., Hietala, S., and Bryant, M.
    Recombinant influenza A virus vaccines for the pathogenic human A Hong Kong 97 (H5N1) viruses.
    Journal of Infectious Diseases, 1999, 179(5), 1132-1138.
  11. MINUTELLO, M., Senatore, F., Cecchinelli, G., Bianchi, M., Andreani, T., Podda, A., and Crovari, P.
    Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons.
    Vaccine, 1999, 17(2), 99-104.
  12. MOSSAKOWSKI, M. J.
    Annual Conference of Polish Association of Neuropathologists on "Encephalitides", Warszawa, May 23, 1998.
    Folia Neuropathologica, 1998, 36(4), 189-90.
  13. READ, R. C., Goodwin, L., Parsons, M. A., Silcocks, P., Kaczmarski, E. B., Parker, A., and Baldwin, T. J.
    Coinfection with influenza B virus does not affect association of Neisseria meningitidis with human nasopharyngeal mucosa in organ culture.
    Infection and Immunity, 1999, 67(6), 3082-3086.
  14. SELVARAJ, N., Moonis, M., and Ravin, P.
    Hemiparesis following influenza vaccination.
    Postgraduate Medical Journal, 1998, 74(876), 633-5.
  15. SINGH, S.
    Aspirin in acute rheumatic fever.
    Indian Pediatrics, 1998, 35(11), 1159-60.
  16. STANKOVA, I. G., Simeonov, M. F., Maximova, V., Galabov, A. S., and Golovinsky, E. V.
    Synthesis and anti-virus activity of some nucleosides analogues.
    Zeitschrift fur Naturforschung. Section C. Journal of Biosciences, 1999, 54(1-2), 75-83.
  17. TANG, P. C., LaRosa, M. P., Newcomb, C., and Gorden, S. M.
    Measuring the effects of reminders for outpatient influenza immunizations at the point of clinical opportunity.
    Journal of the American Medical Informatics Association, 1999, 6(2), 115-21.

    18. Epidemiology

  18. ANONYMOUS
    From the Centers for Disease Control and Prevention. Update: influenza activity--United States, 1998-99 season.
    JAMA, 1998, 281(13), 1165-7.
  19. ANONYMOUS
    Update: influenza activity--United States, 1998-99 season.
    MMWR - Morbidity & Mortality Weekly Report, 1999, 48(9), 177-81.
  20. ANONYMOUS
    Influenza.
    Weekly Epidemiological Record, 1999, 74(11), 86-7.
  21. ANONYMOUS
    From the Centers for Disease Control and Prevention. Update: influenza activity--United States, 1998-99 season.
    JAMA, 1999, 281(13), 1165-7.
  22. GENSHEIMER, K. F., Fukuda, K., Brammer, L., Cox, N., Patriarca, P. A., and Strikas, R. A.
    Preparing for pandemic influenza: the need for enhanced surveillance.
    Emerging Infectious Diseases, 1999, 5(2), 297-9.
  23. KITA, J.
    Epizootic of equine influenza in 1969 in Poland.
    Archivum Veterinarium Polonicum, 1993, 33(3-4), 139-45.
  24. PELLETIER, L., Buck, P., Herman, S., Scott, C., Winchester, B., Zabchuk, P., Sockett, P., and Vanderkloot, M.
    Respiratory virus surveillance. FluWatch project.
    Canada Communicable Disease Report, 1999, 25(6), 62-4.
  25. SNACKEN, R., Kendal, A. P., Haaheim, L. R., and Wood, J. M.
    The next influenza pandemic: lessons from Hong Kong, 1997. [Review] [37 refs].
    Emerging Infectious Diseases, 1999, 5(2), 195-203.
  26. TASHIRO, M.
    [H 5 N1 avian influenza in Hong Kong]. [Review] [21 refs] [Japanese].
    Uirusu, 1998, 48(2), 211-21.
  27. VAN DER POEL, W. H.
    ["Emerging" viral zoonoses in native animals who can be the host in the Netherlands]. [Review] [90 refs] [Dutch].
    Tijdschrift voor Diergeneeskunde, 1999, 124(1), 3-11.

    28. Immunology

  28. AYMARD, M., Gerentes, L., and Kessler, N.
    [Role of antineuraminidase antibodies in protection against influenza]. [French].
    Bulletin de l Academie Nationale de Medecine, 1998, 182(8), 1723-36; discussion 1736-7.
  29. BACHMANN, M. F., Ecabert, B., and Kopf, M.
    Influenza virus: a novel method to assess viral and neutralizing antibody titers in vitro.
    Journal of Immunological Methods, 1999, 225(1-2), 105-111.
  30. FRACE, A. M., Klimov, A. I., Rowe, T., Black, R. A., and Katz, J. M.
    Modified M2 proteins produce heterotypic immunity against influenza A virus.
    Vaccine, 1999, 17(18), 2237-2244.
  31. FU, T. M., Guan, L., Friedman, A., Schofield, T. L., Ulmer, J. B., Liu, M. A., and Donnelly, J. J.
    Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
    Journal of Immunology, 1999, 162(7), 4163-70.
  32. FUJIMOTO, I., Takizawa, T., Ohba, Y., and Nakanishi, Y.
    Co-expression of Fas and Fas-ligand on the surface of influenza virus-infected cells.
    Cell Death & Differentiation, 1998, 5(5), 426-31.
  33. HAANEN, J. B., Toebes, M., Cordaro, T. A., Wolkers, M. C., Kruisbeek, A. M., and Schumacher, T. N.
    Systemic T cell expansion during localized viral infection.
    European Journal of Immunology, 1999, 29(4), 1168-74.
  34. HARTSHORN, K. L. and White, M. R.
    Influenza A virus up-regulates neutrophil adhesion molecules and adhesion to biological surfaces.
    Journal of Leukocyte Biology, 1999, 65(5), 614-622.
  35. HILGERS, L. A., Lejeune, G., Nicolas, I., Fochesato, M., and Boon, B.
    Sulfolipo-cyclodextrin in squalane-in-water as a novel and safe vaccine adjuvant.
    Vaccine, 1999, 17(3), 219-28.
  36. HOQ, M. M., Suzutani, T., Nakaya, K., Yoshida, I., Ogasawara, M., Takeda, Y., Shibaki, T., Itohara, S., Yamamoto, H., and Azuma, M.
    Insufficient resistance of trehalose-6,6 '-dimycolate-treated T-cell receptor delta gene mutant (TCR delta(-/-)) mice against influenza virus infection.
    Microbiology and Immunology, 1999, 43(5), 491-493.
  37. IWASAKI, T., Tamura, S., Kumasaka, T., Sato, Y., Hasegawa, H., Asanuma, H., Aizawa, S., Yanagihara, R., and Kurata, T.
    Exacerbation of influenzavirus pneumonia by intranasal administration of surfactant in a mouse model.
    Archives of Virology, 1999, 144(4), 675-685.
  38. KOCHS, G. and Haller, O.
    Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids.
    Proceedings of the National Academy of Sciences of the United States of America, 1999, 96(5), 2082-6.
  39. LUNN, D. P., Soboll, G., Schram, B. R., Quass, J., McGregor, M. W., Drape, R. J., Macklin, M. D., McCabe, D. E., Swain, W. F., and Olsen, C. W.
    Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene.
    Vaccine, 1999, 17(18), 2245-2258.
  40. MORGAN, D. J., Kurts, C., Kreuwel, H. T., Holst, K. L., Heath, W. R., and Sherman, L. A.
    Ontogeny of T cell tolerance to peripherally expressed antigens.
    Proceedings of the National Academy of Sciences of the United States of America, 1999, 96(7), 3854-8.
  41. NAKAGAWA, N., Maeda, A., Kase, T., Kubota, R., and Okuno, Y.
    Rapid detection and identification of two lineages of influenza B strains with monoclonal antibodies.
    Journal of Virological Methods, 1999, 79(1), 113-120.
  42. NATARAJAN, S. K., Assadi, M., and Sadegh-Nasseri, S.
    Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides.
    Journal of Immunology, 1999, 162(7), 4030-6.
  43. PERTMER, T. M. and Robinson, H. L.
    Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein.
    Virology, 1999, 257(2), 406-414.
  44. SIGAL, L. J. and Wylie, D. E.
    Role of non-anchor residues of Db-restricted peptides in class I binding and TCR triggering.
    Molecular Immunology, 1996, 33(17-18), 1323-33.
  45. STRYHN, A., Pedersen, L. O., Romme, T., Holm, C. B., Holm, A., and Buus, S.
    Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding.
    European Journal of Immunology, 1996, 26(8), 1911-8.

    46. Structure, function and genetics

  46. AKHTAR, N., Ni, J., Stromberg, D., Rosenthal, G. L., Bowles, N. E., and Towbin, J. A.
    Tracheal aspirate as a substrate for polymerase chain reaction detection of viral genome in childhood pneumonia and myocarditis.
    Circulation, 1999, 99(15), 2011-8.
  47. CHEN, Z. Y., Li, Y. Z., and Krug, R. M.
    Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3 '-end processing machinery.
    EMBO Journal, 1999, 18(8), 2273-2283.
  48. DOAN, L., Handa, B., Roberts, N. A., and Klumpp, K.
    Metal ion catalysis of RNA cleavage by the influenza virus endonuclease.
    Biochemistry, 1999, 38(17), 5612-5619.
  49. KAVERIN, N. V. and Klenk, H. D.
    Strain-specific differences in the effect of influenza A virus neuraminidase on vector-expressed hemagglutinin.
    Archives of Virology, 1999, 144(4), 781-786.
  50. KORTE, T., Ludwig, K., Booy, F. P., Blumenthal, R., and Herrmann, A.
    Conformational intermediates and fusion activity of influenza virus hemagglutinin.
    Journal of Virology, 1999, 73(6), 4567-4574.
  51. LAZAREV, V. N., Shmarov, M. M., Zakhartchouk, A. N., Yurov, G. K., Misurina, O. U., Akopian, T. A., Grinenko, N. F., Grodnitskaya, N. G., Kaverin, N. V., and Naroditsky, B. S.
    Inhibition of influenza A virus reproduction by a ribozyme targeted against PB1 mRNA.
    Antiviral Research, 1999, 42(1), 47-57.
  52. MASUNAGA, K., Mizumoto, K., Kato, H., Ishihama, A., and Toyoda, T.
    Molecular mapping of influenza virus RNA polymerase by site-specific antibodies.
    Virology, 1999, 256(1), 130-41.
  53. MILLAR, B. M. G., Calder, L. J., Skehel, J. J., and Wiley, D. C.
    Membrane fusion by surrogate receptor-bound influenza haemagglutinin.
    Virology, 1999, 257(2), 415-423.
  54. POON, L. L., Pritlove, D. C., Fodor, E., and Brownlee, G. G.
    Direct evidence that the poly(A) tail of influenza A virus mRNA is synthesized by reiterative copying of a U track in the virion RNA template.
    Journal of Virology, 1999, 73(4), 3473-6.
  55. REUTER, J. D., Myc, A., Hayes, M. M., Gan, Z., Roy, R., Qin, D., Yin, R., Piehler, L. T., Esfand, R., Tomalia, D. A., and Baker, J. R. Jr
    Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers.
    Bioconjugate Chemistry, 1999, 10(2), 271-8.
  56. ZHANG, X. D., Rosenthal, P. B., Formanowski, F., Fitz, W., Wong, C. H., MeierEwert, H., Skehel, J. J., and Wiley, D. C.
    X-ray crystallographic determination of the structure of the influenza C virus haemagglutinin-esterase-fusion glycoprotein.
    Acta Crystallographica Section D Biological Crystallography, 1999, 55, 945-961.
  57. ZHENG, H. Y., Lee, H. A., Palese, P., and GarciaSastre, A.
    Influenza A virus RNA polymerase has the ability to stutter at the polyadenylation site of a viral RNA template during RNA replication.
    Journal of Virology, 1999, 73(6), 5240-5243.